{
    "id": 2560,
    "fullName": "BRAF F595L",
    "impact": "missense",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "BRAF F595L lies within the protein kinase domain of the Braf protein (UniProt.org). F595L results in reduced Braf kinase activity (PMID: 28783719, PMID: 15035987), but works cooperatively with oncogenic Ras to activate MEK/ERK signaling, and is transforming in cell culture (PMID: 15035987, PMID: 26582644, PMID: 29533785).",
            "references": [
                {
                    "id": 146,
                    "pubMedId": 15035987,
                    "title": "Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/15035987"
                },
                {
                    "id": 11238,
                    "pubMedId": 29533785,
                    "title": "Systematic Functional Annotation of Somatic Mutations in Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29533785"
                },
                {
                    "id": 9692,
                    "pubMedId": 28783719,
                    "title": "Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28783719"
                },
                {
                    "id": 9695,
                    "pubMedId": 26582644,
                    "title": "Cooperation of BRAF(F595L) and mutant HRAS in histiocytic sarcoma provides new insights into oncogenic BRAF signaling.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26582644"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 673,
        "geneSymbol": "BRAF",
        "terms": [
            "BRAF",
            "B-raf",
            "B-RAF1",
            "BRAF1",
            "NS7",
            "RAFB1"
        ]
    },
    "variant": "F595L",
    "createDate": "11/11/2014",
    "updateDate": "11/05/2019",
    "referenceTranscriptCoordinates": {
        "id": 109108,
        "transcript": "NM_004333",
        "gDna": "chr7:g.140753352A>G",
        "cDna": "c.1783T>C",
        "protein": "p.F595L",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 11664,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, treatment with Zelboraf (vemurafenib) did not reduce activation of Mek and Erk by BRAF F595L in transformed cells in culture (PMID: 26582644).",
            "molecularProfile": {
                "id": 2417,
                "profileName": "BRAF F595L"
            },
            "therapy": {
                "id": 342,
                "therapyName": "Vemurafenib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 9695,
                    "pubMedId": 26582644,
                    "title": "Cooperation of BRAF(F595L) and mutant HRAS in histiocytic sarcoma provides new insights into oncogenic BRAF signaling.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26582644"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 2417,
            "profileName": "BRAF F595L",
            "profileTreatmentApproaches": [
                {
                    "id": 14751,
                    "name": "MEK inhibitor (Pan)",
                    "profileName": "BRAF F595L"
                },
                {
                    "id": 14753,
                    "name": "MEK1 Inhibitor",
                    "profileName": "BRAF F595L"
                },
                {
                    "id": 14752,
                    "name": "MEK2 Inhibitor",
                    "profileName": "BRAF F595L"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 109108,
            "transcript": "NM_004333",
            "gDna": "chr7:g.140753352A>G",
            "cDna": "c.1783T>C",
            "protein": "p.F595L",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 109107,
            "transcript": "XM_005250045",
            "gDna": "chr7:g.140753352A>G",
            "cDna": "c.1783T>C",
            "protein": "p.F595L",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}